Collectively, these data suggest that disruption of Plpp3 during embryonic central nervous system (CNS) development does not cause ventral midbrain DA neuron loss or locomotor impairments consistent with PD, but results in dopaminergic transmission deficits that might contribute to the pathology under specific contexts. Here, PLPP3 is linked to Parkinson disease.